Liao, S., Zhang, W., Hu, X., Wang, W., Deng, D., Wang, H., … Ma, D. (2015). A novel "priming-boosting" strategy for immune interventions in cervical cancer. Molecular Immunology, 64(2), 295-305. https://doi.org/10.1016/j.molimm.2014.12.007 (Original work published 2015)
AAV
Cramer, M., Shao, G., Rodino-Klapac, L., Chicoine, L., & Martin, P. (2017). Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone. Human Gene Therapy, 28(6), 493-509. https://doi.org/10.1089/hum.2016.113 (Original work published 2017)
Potter, R., Griffin, D., Sondergaard, P., Johnson, R., Pozsgai, E., Heller, K., … Rodino-Klapac, L. (2018). Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy. Human Gene Therapy, 29(7), 749-762. https://doi.org/10.1089/hum.2017.062 (Original work published 2018)
Chung, S., Mollhoff, I., Mishra, A., Sin, T.-N., Ngo, T., Ciulla, T., … Yiu, G. (2021). Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes. Human Gene Therapy, 32(13-14), 682-693. https://doi.org/10.1089/hum.2020.281 (Original work published 2021)
Flanigan, K., Vetter, T., Simmons, T., Iammarino, M., Frair, E., Rinaldi, F., … Martin, P. (2022). A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2. Molecular Therapy. Methods & Clinical Development, 27, 47-60. https://doi.org/10.1016/j.omtm.2022.08.009 (Original work published 2022)